2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on …
Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …
[PDF][PDF] 2015 年中国恶性肿瘤流行情况分析
郑荣寿, 孙可欣, 张思维, 曾红梅, 邹小农, 陈茹… - 中华肿瘤 …, 2019 - researchgate.net
目的汇总分析各省肿瘤登记处上报的2015 年恶性肿瘤登记数据, 估算全国2015
年恶性肿瘤流行情况. 方法收集整理各省501 个登记处上报的2015 年肿瘤登记数据 …
年恶性肿瘤流行情况. 方法收集整理各省501 个登记处上报的2015 年肿瘤登记数据 …
Lung cancer immunotherapy: progress, pitfalls, and promises
A Lahiri, A Maji, PD Potdar, N Singh, P Parikh, B Bisht… - Molecular cancer, 2023 - Springer
Lung cancer is the primary cause of mortality in the United States and around the globe.
Therapeutic options for lung cancer treatment include surgery, radiation therapy …
Therapeutic options for lung cancer treatment include surgery, radiation therapy …
Breast cancer statistics, 2022
This article is the American Cancer Society's update on female breast cancer statistics in the
United States, including population‐based data on incidence, mortality, survival, and …
United States, including population‐based data on incidence, mortality, survival, and …
Cancer statistics in China and United States, 2022: profiles, trends, and determinants
Background: The cancer burden in the United States of America (USA) has decreased
gradually. However, China is experiencing a transition in its cancer profiles, with greater …
gradually. However, China is experiencing a transition in its cancer profiles, with greater …
Overview of the 2022 WHO classification of thyroid neoplasms
This review summarizes the changes in the 5th edition of the WHO Classification of
Endocrine and Neuroendocrine Tumors that relate to the thyroid gland. The new …
Endocrine and Neuroendocrine Tumors that relate to the thyroid gland. The new …
Neoadjuvant chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer: long-term results of the Dutch randomized …
E Versteijne, JL van Dam, M Suker… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE The benefit of neoadjuvant chemoradiotherapy in resectable and borderline
resectable pancreatic cancer remains controversial. Initial results of the PREOPANC trial …
resectable pancreatic cancer remains controversial. Initial results of the PREOPANC trial …
Thyroid carcinoma, version 2.2022, NCCN clinical practice guidelines in oncology
RI Haddad, L Bischoff, D Ball, V Bernet… - Journal of the National …, 2022 - jnccn.org
Differentiated thyroid carcinomas is associated with an excellent prognosis. The treatment of
choice for differentiated thyroid carcinoma is surgery, followed by radioactive iodine ablation …
choice for differentiated thyroid carcinoma is surgery, followed by radioactive iodine ablation …
Targeted therapies for lung cancer patients with oncogenic driver molecular alterations
Lung cancer has traditionally been classified by histology. However, a greater
understanding of disease biology and the identification of oncogenic driver alterations has …
understanding of disease biology and the identification of oncogenic driver alterations has …
Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers
The accurate identification of antitumor T cell receptors (TCRs) represents a major challenge
for the engineering of cell-based cancer immunotherapies. By mapping 55 neoantigen …
for the engineering of cell-based cancer immunotherapies. By mapping 55 neoantigen …